跳至主要内容
临床试验/CTRI/2016/07/007117
CTRI/2016/07/007117进行中(未招募)1 期

A RANDOMIZED, SINGLE CENTER, DOUBLE BLIND, TWO-PERIOD, CROSSOVER GLUCOSE CLAMP STUDY TO TEST BIOEQUIVALENCE BETWEEN TWO FORMULATIONS OF RECOMBINANT HUMAN INSULINS; WOSULIN R (200 IU) WITH WOSULIN R (100 IU) IN HEALTHY SUBJECTS.

Wockhardt Limited1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2016年7月25日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
56
试验地点
1
主要终点
PD: AUC (GIR, 0-12h), and GIRmax

研究概览

简要总结

Study yet to be initiated

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
14.00 Year(s) 至 45.00 Year(s)(—)
性别
Male

入选标准

  • •1.Body Mass Index (BMI) between 18.0 and 27.0 kg/m2, (both inclusive) 2.Subjects with normal results of 2 hours Oral Glucose Tolerance Test (OGTT) performed at screening.
  • •Considered generally healthy upon completion of medical history, physical examination, X-ray chest (PA view), ECG, and biochemical investigations.

排除标准

  • •HbA1c values (at screening) more than 5.7%.

结局指标

主要结局

PD: AUC (GIR, 0-12h), and GIRmax

时间窗: PK: 12 hours | PD: 12 hours

PK: AUC0-12 and Cmax

时间窗: PK: 12 hours | PD: 12 hours

次要结局

  • PK endpoints: AUC0-4h, AUC0-6h, AUC6-12h, AUC0- ï‚¥, tmax, t½ and elimination rate(constant (ï¬z))

研究者

申办方类型
Pharmaceutical industry-Global

研究点 (1)

Loading locations...

相似试验

已完成
1 期
Bioequivalence and bioavailability study on InsulinDiabetes
CTRI/2017/08/009251Wockhardt Pvt Ltd50
Unknown
3 期
A Randomized, Double Blind, Single Centre, study to assess the efficacy, safety and tolerability of the Gastrin Receptor Antagonist (GRA), Netazepide administered for 90 days, in post-menopausal women (OSTEO-GRA)Musculoskeletal Diseases
PACTR202407466904092niversity of Cape Town90
进行中(未招募)
不适用
A Single Centre, Double-blind, Randomised Study To Investigate a Single Oral Dose of IMD-1041 in A Nasal Allergen Challenge (NAC) ModelIt is intended to investigate the potential therapeutic benefit of IKKß inhibition in man by oral dosing of IMD-1041 in a Nasal Alllergen Challenge.MedDRA version: 14.1Level: PTClassification code 10053467Term: Antiinflammatory therapySystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2007-000190-28-GBInstitute of Medicinal Molecular Design Inc12
已完成
不适用
Study of the efficacy and safety indicators of two different iron chelators in patients with iron overload (Estudio de los indicadores de eficacia y seguridad de dos quelantes del hierro en pacientes con sobrecarga ferrica)HaemosiderosisHaematological DisordersDisorders of iron metabolism
ISRCTN52984371Aragon Institute of Health Sciences [Instituto Aragonés de Ciencias de la Salud] (Spain)32
招募中
1 期
A Study to Evaluate the Efficacy, Safety and Tolerability of a Single Injection of AC102 into the Middle Ear Compared to Oral Steroid Treatment in Patients with Sudden Hearing Loss.Idiopathic Sudden Sensorineural Hearing Loss
CTIS2024-513658-31-00AudioCure Pharma GmbH207